Document is current
Any future updates will be listed below
-
Authors
Zhao, Xin https://orcid.org/0009-0004-1540-2149
Li, Yang https://orcid.org/0000-0001-5265-2375
Zhang, Hongyan
Cai, Yihang
Wang, Xu
Liu, Yidu
Li, Tingting
Xu, Chendong
Teng, Yuee https://orcid.org/0000-0002-9198-9795
Li, Danni https://orcid.org/0000-0001-7647-864X
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (31970741, 32170725, 82103174, 82003296)
Natural Science Foundation of Liaoning Province (2022-MS-197)
Shenyang Science and Technology Bureau (RC230707)
- License Information
-
More Information
Article History
Received: 8 November 2024
Revised: 7 April 2025
Accepted: 10 April 2025
First Online: 21 April 2025
Competing interests
: The authors declare no competing interests.
: All human breast tumor samples were obtained from patients with informed consent. The current study was approved by the Institutional Review Board for human study of China Medical University and conducted according to the principles expressed in the Helsinki Declaration. The animal study (protocol# CMU2023947) was approved by the Institutional Animal Care and Use Committee of China Medical University and conducted in compliance with relevant local guidelines and regulations.
